Clinical Analysis: Hypokalemic Periodic Paralysis with Respiratory Compromise

Diagnosis: Hypokalemic Periodic Paralysis (HypoPP) — Most likely Thyrotoxic Periodic Paralysis (TPP)

Why This Diagnosis Fits

Pathophysiology

Immediate Priorities (This is a Medical Emergency)

1. Airway & Respiratory Support

• Assess ABG urgently — rising PaCO₂ signals hypoventilatory respiratory failure
• Low threshold for intubation and mechanical ventilation given K⁺ = 1.2 with active dyspnea
• Monitor SpO₂ and respiratory rate continuously

2. Potassium Replacement — Cautiously

Critical caveat: Because the hypokalemia is due to intracellular shift (not depletion), aggressive repletion risks rebound hyperkalemia once the attack resolves.

• Administer IV KCl at 10 mmol/hour in 0.9% saline (NOT dextrose-containing solutions — insulin release from dextrose would worsen hypokalemia by pushing more K⁺ intracellularly)
• Recheck K⁺ every 1–2 hours
• Parallel oral KCl 40 mEq if able to swallow safely
• Rosen's Emergency Medicine recommends 1–2 boluses of 10 mEq IV KCl, each over 1 hour, not wholesale large-volume replacement
• Brenner & Rector documents rebound hyperkalemia (K⁺ rose to 5.7) after only 80 mmol KCl in a similar patient

3. Avoid Triggers

• No glucose/dextrose-containing IV fluids
• No beta-2 agonists (shift K⁺ further into cells)

Essential Workup

Differential Diagnosis to Consider

1. Thyrotoxic Periodic Paralysis (TPP) — most likely given adult female, profound hypokalemia, proximal-then-distal pattern. TPP is clinically identical to familial HypoPP but is acquired; signs of thyrotoxicosis may be subtle
2. Familial Hypokalemic Periodic Paralysis (HypoPP Type 1 or 2) — mutation in CACNA1S (Ca channel) or SCN4A (Na channel)
3. Hyperaldosteronism (Conn's syndrome) — causes renal K⁺ wasting (urine K⁺ will be high); metabolic alkalosis present
4. Barium poisoning / licorice toxicity — rare, mimics HypoPP
5. GBS — can cause progressive areflexic flaccid paralysis with respiratory failure, but K⁺ would be normal and CSF shows albuminocytologic dissociation

Key Distinguishing Feature from GBS

Definitive Treatment of TPP

• Non-selective beta-blocker (propranolol) acutely — blocks adrenergic stimulation of Na⁺/K⁺-ATPase, rapidly improving hypokalemia and paralysis with less risk of rebound hyperkalemia
• Treat hyperthyroidism definitively (anti-thyroid drugs: methimazole/carbimazole, radioiodine, or surgery)
• Once euthyroid, attacks cease completely

• Prophylaxis: acetazolamide or dichlorphenamide (FDA-approved, carbonic anhydrase inhibitor)
• Potassium-sparing diuretics (spironolactone) as alternative

Bottom Line

Clinical Diagnosis: Severe Hypokalemic Periodic Paralysis — Most Likely Thyrotoxic Periodic Paralysis (TPP)

Putting the Clues Together

Why Absent F-Waves Here

• Sustained depolarization of the muscle membrane → inexcitability
• Impaired axonal conduction in the most severely affected fibers

"In the early phases of Guillain-Barré syndrome, findings on routine motor nerve studies may be normal except for prolonged or absent F waves" — Bradley & Daroff's Neurology — but that requires normal K⁺ and CSF protein elevation.

Differential Diagnosis

🚨 This is a Medical Emergency

Pathophysiology

Immediate Management

Step 1: Airway & Breathing — TOP PRIORITY

• ABG urgently: Rising PaCO₂ = hypoventilatory respiratory failure → intubate early, do not wait for crisis
• Continuous SpO₂, respiratory rate monitoring
• Call ICU

Step 2: ECG

• Hypokalemia at 1.2 mEq/L: look for flattened/inverted T-waves, prominent U-waves, QT prolongation, ventricular ectopics, arrhythmia
• Cardiac monitoring continuously

Step 3: Potassium Replacement — With Great Caution

⚠️ The hypokalemia is due to intracellular K⁺ shift, not total body depletion. Aggressive replacement causes rebound hyperkalemia when the attack resolves.

• IV KCl 10 mEq over 1 hour in 0.9% normal saline — repeat ×1–2 doses maximum initially
• Do NOT use dextrose-containing fluids — insulin release worsens intracellular K⁺ shift and deepens hypokalemia
• Concurrent oral KCl 40 mEq if airway is protected and swallow is safe
• Recheck serum K⁺ every 1–2 hours
• Brenner & Rector documents rebound hyperkalemia (K⁺ rose to 5.7 mmol/L) in a similar patient who received only 80 mmol KCl

Step 4: Non-selective Beta-Blocker (if TPP suspected)

• Propranolol 160 mg/day in divided doses (Adams & Victor's) — blocks adrenergic stimulation of Na⁺/K⁺-ATPase
• Acutely corrects hypokalemia with less rebound hyperkalemia risk than K⁺ replacement alone
• Also treats concurrent tachycardia/thyrotoxic symptoms

Urgent Investigations

Definitive Treatment

• Treat hyperthyroidism definitively — methimazole / carbimazole, radioiodine, or thyroidectomy
• Adams & Victor's Principles of Neurology: "Effective treatment of the hyperthyroidism abolishes the periodic attacks in more than 90% of cases"
• Propranolol for prophylaxis and acute attack management

• Prophylaxis: acetazolamide or dichlorphenamide (FDA-approved)
• Potassium-sparing diuretics (spironolactone) as alternative
• Avoid triggers: high-carbohydrate meals, rest after exercise, alcohol, cold exposure

Key Clinical Pearls

1. Never use dextrose in these patients — it worsens hypokalemia
2. Absent F-waves in the context of profound hypokalemia = reversible electrophysiological block, NOT GBS demyelination
3. Respiratory muscle involvement is uncommon but life-threatening — K⁺ of 1.2 puts this patient at high risk
4. Signs of thyrotoxicosis may be subtle — tachycardia, systolic hypertension, mild tremor, or none at all
5. This patient's UK/UCl ratio will distinguish shift (TPP/familial HypoPP) from true renal K⁺ loss